Previous data from our group [24] indicated that a selected radioresistant subpopulation of lung and breast cancer cells presenting the CSC marker ALDH1 can be sensitized to ionizing radiation by treatment with the ALDH1 inhibitor DEAB or the PI3K inhibitor LY294002. This evidence concerns the gene ALDH1A1 and breast carcinoma.